Journal of Molecular Medicine

• Sender: owner-newjour@ccat.sas.upenn.edu

James Renfro wrote:
From: James Renfro <jrenfro@dolphin.upenn.edu>
Subject: Journal of Molecular Medicine
To: nj@ccat.sas.upenn.edu (NewJour)
Date: Mon, 21 Jul 1997 16:00:42 -0400 (EDT)

Journal of Molecular Medicine

http://www.springerlink.com/content/100437/

The official publication of the German Working Group for Gene Therapy
(DAG-GT) and the Biomedical Research Association (KBF), the Journal of
Molecular Medicine (JMM) publishes original papers, rapid communications,
review articles and correspondence of the highest quality pertinent to all
aspects of human biology and pathophysiology. The application of research
involving gene technology, gene therapy, molecular structural analysis,
genetic epidemiology and molecular and clinical pharmacology has made
unprecedented progress and precision possible in the understanding,
prevention, diagnosis and treatment of human diseases. These areas of
molecular medicine, therefore, will be given particular attention by the
editorial board. Papers describing in vitro or animal studies will be
accepted, if they are relevant to normal or pathological human biology. 

The electronic version of the journal is published monthly, and full-text 
articles are available online to subscribers in Adobe Acrobat portable 
document format.

Subscription Information:
  North America: Recommended annual subscription rate: approx. US $ 434.00 
  (single issue price: approx. US $ 42.00) including carriage charges. 
  Subscriptions are entered with prepayment only.

ISSN: 0946-2716 (printed version)
ISSN: 1432-1440 (electronic version)

Editor in Chief: D. Ganten 
Email: helpdesk@link.springer.de